Development and antitumor activity of a BCL-2 targeted single-stranded DNA oligonucleotide

The accessible chromatin landscape of the human genome

Robert E. Thurman, Eric Rynes, Richard Humbert et al. · Nature · 2012 · 2.8K citations · Full text

Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms

Akin Akinc, William Querbes, Soma De et al. · Molecular Therapy · 2010 · 1.1K citations · Full text

Nanotherapeutics, Engineering, Immunology +17

Antisense oligonucleotides: basic concepts and mechanisms.

Nathalie Dias, C.A. Stein · PubMed · 2002 · 750 citations

Dna, Engineering, Genetics +17

Identification of a p53-dependent negative response element in the bcl-2 gene.

Toshiyuki Miyashita, Masayoshi Harigai, Masahito Hanada et al. · PubMed · 1994 · 747 citations

Cancer Research, Cell Regulation, Medicine +13

Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Tina Green, Ken H. Young, Carlo Visco et al. · Journal of Clinical Oncology · 2012 · 677 citations · Full text